Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs McKesson Corporation (MCK) Price & Performance

ARK Genomic Revolution ETFTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

ARK Genomic Revolution ETF vs McKesson Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: McKesson Corporation pays a 0.42% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.

ARKGMCK
Sector
Sector/ThematicHealth
52-Week High
$44.55$995.69
52-Week Low
$24.02$659.01
Market Cap
$105.14B
Enterprise Value
$111.67B
Dividend Yield
0.42%

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK